论文部分内容阅读
根据上海医药站、上海市医药公司、济南医药站、青岛医药站、济宁医药(集团)总公司、淄博医药站、福建省医药公司、福州医药站、厦门医药站、杭州医药站、宁波医药站、金华医药站、江西省医药公司、南昌市医药公司、芜湖医药站、江苏省医药公司、盐城医药站、南通医药股份有限公司、无锡医药站、常州药业股份有限公司、苏州医药站、南京医药股份有限公司等22个单位,关于1993年度40个进口药品销售与库存动态通报资料。其中与92年同期资料可比性有18个单位,现汇总综合通报如下,以供参考。一、销售趋势: 根据市场供求动态,综合通报资料反映,
According to Shanghai Pharmaceutical Station, Shanghai Pharmaceutical Company, Jinan Medical Station, Qingdao Medical Station, Jining Pharmaceutical (Group) Corporation, Zibo Pharmaceutical Station, Fujian Pharmaceutical Company, Fuzhou Pharmaceutical Station, Xiamen Medical Station, Hangzhou Medical Station, Ningbo Medical Station , Jinhua Medical Station, Jiangxi Provincial Pharmaceutical Company, Nanchang Pharmaceutical Company, Wuhu Pharmaceutical Station, Jiangsu Provincial Pharmaceutical Company, Yancheng Pharmaceutical Station, Nantong Pharmaceutical Co., Ltd., Wuxi Pharmaceutical Station, Changzhou Pharmaceutical Co., Ltd., Suzhou Pharmaceutical Station, Nanjing Pharmaceutical Co., Ltd. and other 22 units, on the 40 imported drugs in 1993 sales and inventory dynamic notification information. Among them, there are 18 units that are comparable with the data of the same period of 1992, and are now summarized in the following summary for reference. First, the sales trend: According to the market supply and demand dynamics, comprehensive communication of information reflect,